{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:08:11Z","timestamp":1785276491471,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bcp.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T23:20:25Z","timestamp":1520378425000},"page":"69-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Identification of enzymes responsible for dantrolene metabolism in the human liver: A clue to uncover the cause of liver injury"],"prefix":"10.1016","volume":"151","author":[{"given":"Takayuki","family":"Amano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Ogiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2018.03.002_b0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7326\/0003-4819-84-1-53","article-title":"Hepatitis associated with dantrolene sodium","volume":"84","author":"Ogburn","year":"1976","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcp.2018.03.002_b0010","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/jama.1976.03260410046023","article-title":"Dantrolene hepatitis","volume":"235","author":"Schneider","year":"1976","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2018.03.002_b0015","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0016-5085(77)80141-8","article-title":"Dantrolene-associated hepatic injury. Incidence and character","volume":"72","author":"Utili","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2018.03.002_b0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1021\/tx600260a","article-title":"Applying mechanisms of chemical toxicity to predict drug safety","volume":"20","author":"Guengerich","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bcp.2018.03.002_b0025","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0090-9556(25)08185-1","article-title":"Identification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes","volume":"21","author":"Jayyosi","year":"1993","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.03.002_b0030","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1124\/dmd.110.037077","article-title":"Development of a highly sensitive cytotoxicity assay system for CYP3A4-mediated metabolic activation","volume":"39","author":"Hosomi","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.03.002_b0035","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/0006-2952(87)90520-X","article-title":"Induction of hepatic cytochrome P-450c-dependent monooxygenase activities by dantrolene in rat","volume":"36","author":"Jayyosi","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.03.002_b0040","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0022-3565(25)24502-5","article-title":"Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides","volume":"244","author":"Rieder","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2018.03.002_b0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1254\/jjp.24.195","article-title":"Effects of lyophilization and storage of rat liver microsomes on activity of aniline hydroxylase, contents of cytochrome b5 and cytochrome p-450 and aniline-induced p-450 difference spectrum","volume":"24","author":"Kamataki","year":"1974","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.03.002_b0050","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1124\/dmd.109.029520","article-title":"Purification and mechanism of human aldehyde oxidase expressed in Escherichia coli","volume":"37","author":"Alfaro","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.03.002_b0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0091270003260336","article-title":"Human liver aldehyde oxidase: inhibition by 239 drugs","volume":"44","author":"Obach","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2018.03.002_b0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1124\/dmd.32.1.89","article-title":"Potent inhibition of human liver aldehyde oxidase by raloxifene","volume":"32","author":"Obach","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.03.002_b0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0022-3565(25)29499-X","article-title":"Nitroreductase activity of mammalian liver aldehyde oxidase","volume":"185","author":"Wolpert","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2018.03.002_b0070","unstructured":"K.F. Windmill, A. Gaedigk, P.D.M. Hall, H. Samaratunga, D.M. Grant, M.E. Mcmanus, Localization of N-acetyltransferases NAT1 and NAT2 in human tissues, 29 (2000) 19\u201329."},{"key":"10.1016\/j.bcp.2018.03.002_b0075","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/138920006778520606","article-title":"Bioactivation and hepatotoxicity of nitroaromatic drugs","volume":"7","author":"Boelsterli","year":"2006","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bcp.2018.03.002_b0080","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.40.9.1427","article-title":"Dantrolene sodium and hepatic injury","volume":"40","author":"Chan","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2018.03.002_b0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0006-2952(02)01068-7","article-title":"Carbonyl reduction of the potential cytostatic drugs benfluron and 3,9-dimethoxybenfluron in human in vitro","volume":"64","author":"Sk\u00e1lov\u00e1","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.03.002_b0090","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1124\/dmd.108.022251","article-title":"Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver","volume":"36","author":"Kassner","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.03.002_b0095","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.clpt.6100078","article-title":"Developmental changes of aldehyde oxidase activity in young Japanese children","volume":"81","author":"Tayama","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2018.03.002_b0100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1211\/0022357991772619","article-title":"Aldehyde oxidase-catalysed oxidation of methotrexate in the liver of guinea-pig, rabbit and man","volume":"51","author":"Jordan","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bcp.2018.03.002_b0105","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/00498250210158915","article-title":"Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase","volume":"32","author":"Lake","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2018.03.002_b0110","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1124\/dmd.114.061804","article-title":"A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834","volume":"43","author":"Sodhi","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.03.002_b0115","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/carcin\/12.9.1545","article-title":"Kinetics and cofactor requirements for the nitroreductive metabolism of 1-nitropyrene and 3-nitrofluoranthene by rabbit liver aldehyde oxidase","volume":"12","author":"Bauer","year":"1991","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2018.03.002_b0120","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bcp.2017.09.002","article-title":"The two faces of aldehyde oxidase: oxidative and reductive transformations of 5-nitroquinoline","volume":"145","author":"Paragas","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.03.002_b0125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bcp.2017.06.114","article-title":"Identification of enzymes responsible for nitrazepam metabolism and toxicity in human","volume":"140","author":"Konishi","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.03.002_b0130","first-page":"1","article-title":"Properties of aldehyde oxidase as a drug-metabolizing enzyme","volume":"56","author":"Tanaka","year":"2009","journal-title":"J. Tohoku Pharm. Univ."},{"key":"10.1016\/j.bcp.2018.03.002_b0135","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1124\/dmd.114.057984","article-title":"Aldehyde oxidase activity in donor-matched fresh and cryopreserved human hepatocytes and assessment of variability in 75 donors","volume":"42","author":"Hutzler","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.03.002_b0140","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1124\/dmd.111.043828","article-title":"The impact of single nucleotide polymorphisms on human aldehyde oxidase","volume":"40","author":"Hartmann","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.03.002_b0145","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tox.2004.10.009","article-title":"Identification of aldehyde oxidase 1 and aldehyde oxidase homologue 1 as dioxin-inducible genes","volume":"207","author":"Rivera","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2018.03.002_b0150","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.gene.2012.06.010","article-title":"Aldehyde oxidase 1 gene is regulated by Nrf2 pathway","volume":"505","author":"Maeda","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2018.03.002_b0155","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1016\/S0021-9258(19)39609-7","article-title":"Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver","volume":"265","author":"Ohsako","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.03.002_b0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10038-007-0237-z","article-title":"Polymorphisms of promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in the Indonesian population: proposal for a new nomenclature","volume":"53","author":"Yuliwulandari","year":"2008","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bcp.2018.03.002_b0165","first-page":"507","article-title":"Interaction of dantrolene with the hepatic mixed function oxidase system","volume":"27","author":"Roy","year":"1980","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.bcp.2018.03.002_b0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bmc.2005.07.053","article-title":"Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors","volume":"14","author":"Klecker","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2018.03.002_b0175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/bdd.494","article-title":"Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase","volume":"27","author":"Itoh","year":"2006","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.bcp.2018.03.002_b0180","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1124\/dmd.107.019075","article-title":"Aldehyde oxidase-catalyzed metabolism of N1-methylnicotinamide in vivo and in vitro in chimeric mice with humanized liver","volume":"36","author":"Kitamura","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2018.03.002_b0185","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/dmd.110.032375","article-title":"Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications","volume":"38","author":"Diamond","year":"2010","journal-title":"Drug Metab. Dispos."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218300911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218300911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T12:31:41Z","timestamp":1751459501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218300911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":37,"alternative-id":["S0006295218300911"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.03.002","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of enzymes responsible for dantrolene metabolism in the human liver: A clue to uncover the cause of liver injury","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}